Overton Brooks Research Corporation

National institutes of health (nih) study 2016-05 all of us with dr. philip haddad as principal investigator(1) the program invites people in the usa to help build diverse health databases. At this va, the goal is 40 enrollees monthly. A blood draw is required. (2) the goal is to accelerate medical Research breakthroughs by delivering one of the largest biomedical datasets to researchers with one million or more enrolled. (3) it may take years to understand how a variable is linked to a disease or treatment, but by creating a database of this size/scope, nih hopes to speed up this process.

Csl behring, llc study 1214 with dr. neeraj tandon as principal investigator(1) this pharmaceutical study is investigating the efficacy and safety of a drug called csl 112. (2) globally 10,584 participants have enrolled, but only one from this vamc due to the strict inclusion/exclusion criteria. The long term goal is to reduce future cardiovascular events in patients who have had a heart attack. (3) the one veteran enrolled locally has had no adverse events and is being followed per protocol.

Study 1074: prominent pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes

Novartis pharmaceuticals Corporation study qi23-001 with dr. sandra brown as principal investigator. (1) this study contacts veterans receiving care at Overton Brooks vamc concerning their cholesterol levels. There are over 37,000 veterans served at this facility. (2) the long term goal is to improve the cholesterol health through contact with a health care coach. (3) this is a multi-site study with no fixed statistical goal other than to apply existing knowledge to develop individualized care solutions to lower cholesterol in the veteran population. This is not Research requiring institutional review board review.